MoneyWorks4Me

Vineet Laboratories - Quaterly Results

09 Nov 2025 Evaluate
The sales is pegged at Rs. 174.20 millions for the September 2025 quarter. The mentioned figure indicates decline with the sales recorded at Rs. 189.58 millions during the year-ago period.The Total Profit for the quarter ended September 2025 of Rs. 4.00 millions grew from Rs.-18.28 millions Operating profit Margin for the quarter ended September 2025 improved to 31.83% as compared to -1.06% of corresponding quarter ended September 2024


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202509 202409 % Var 202509 202409 % Var 202503 202403 % Var
Sales 174.20 189.58 -8.11 248.62 428.20 -41.94 749.95 1505.91 -50.20
Other Income 0.08 2.00 -96.00 0.26 5.73 -95.46 19.87 4.63 329.16
PBIDT 31.83 -1.06 -3102.83 35.19 -5.29 -765.22 -142.96 76.63 -286.56
Interest 21.87 9.90 120.91 27.99 21.27 31.59 39.78 47.81 -16.80
PBDT 9.96 -10.96 -190.88 7.20 -26.56 -127.11 -182.74 28.82 -734.07
Depreciation 6.25 6.16 1.46 12.50 12.25 2.04 25.02 25.19 -0.67
PBT 3.71 -17.12 -121.67 -5.30 -38.81 -86.34 -207.76 3.63 -5823.42
TAX -0.29 1.16 -125.00 -0.65 0.79 -182.28 -5.85 -6.64 -11.90
Deferred Tax -0.29 1.16 -125.00 -0.65 0.79 -182.28 -5.85 -5.99 -2.34
PAT 4.00 -18.28 -121.88 -4.65 -39.60 -88.26 -201.91 10.27 -2066.02
Equity 92.19 92.19 0.00 92.19 92.19 0.00 92.19 92.19 0.00
PBIDTM(%) 18.27 -0.56 -3368.13 14.15 -1.24 -1245.71 -19.06 5.09 -474.61
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..